[Status epilepticus in MVEC chemotherapy of urothelial cancer].
We present a patient with an urethral urethelial carcinoma (T3N2M0) treated by chemotherapy with methotrexate, vinblastine, epirubicin and cisplatin, which induced a non-convulsive status epilepticus. In this report the possible mechanism for this phenomenon and its management are discussed.
Meessen
S
S
Urologische Klinik, Rheinischen Friedrich-Wilhelms-Universität Bonn.
Riedel
R R
RR
Brühl
P
P
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000097:blood / Q000188:drug therapy*; D004569:Electroencephalography / Q000187:drug effects; D006801:Humans; D008297:Male; D010672:Phenytoin / Q000493:pharmacokinetics / Q000627:therapeutic use; D013226:Status Epilepticus / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy; D014523:Urethral Neoplasms / Q000097:blood / Q000188:drug therapy*
D010672:Phenytoin
Status epilepticus unter MVEC-Chemotherapie eines Urothelkarzinoms.